Agilent Appoints Senior VP and President of Life Sciences and Diagnostics Group
News Dec 18, 2013
Strohmeier has been in charge of Agilent's life sciences business, the largest organization in the LDG business group. He was previously general manager of the Liquid Phase Analysis Division. As a 34-year veteran of the company, he has held positions in R&D, manufacturing and general management. He is based in Waldbronn, Germany.
"Fred is an excellent choice to lead this fast-growing business segment," said William (Bill) Sullivan, Agilent president and CEO. "He is a highly respected leader with a wealth of deep experience and expertise in life sciences products and solutions—the foundation for LDG. Fred was an integral part of the formation of the new LDG, and I look forward to his leadership of the group."
Lars Holmkvist, who previously headed LDG, has left the company for personal reasons.
About Fred Strohmeier
Fred Strohmeier was named senior vice president of Agilent and president of the newly formed Life Sciences and Diagnostics Group (LDG) in December 2013.
Strohmeier has been instrumental in the development of the life sciences business within Agilent, including most recently serving as vice president and general manager of the Life Science Products and Solutions business. This business became the foundation for the creation of LDG, the business group that Strohmeier now leads and was instrumental in forming.
Previously Strohmeier was vice president and general manager of the Liquid Phase Analysis Division, which includes liquid phase separations, software and informatics as well as automation solutions—all key elements of the complete workflow for life sciences labs.
A 34-year veteran of the company, Strohmeier is deeply steeped in all aspects of the business, including R&D, manufacturing and general management.
He holds a degree in mechanical engineering from Karlsruhe University of Applied Sciences in Karlsruhe, Germany.
Strohmeier is based in Waldbronn, Germany, where he has been country president and managing director for Agilent Technologies Deutschland GmbH.
Agilent Technologies Presents Thought Leader Award to Dr. Ram SasisekharanNews
Agilent Technologies awards Dr. Ram Sasisekharan with the Agilent Thought Leader Award in recognition of his contributions in the field of biologics characterization.READ MORE
CRISPR Reveals New Targets for Promising Cancer DrugsNews
Novel screening method identifies new drug targets that could potentially enhance the effectiveness of PD-1 checkpoint inhibitors, a promising new class of cancer immunotherapy.READ MORE
Potential Barcode Identified for a Form of Alcoholic Liver DiseaseNews
NIAAA-supported researchers have discovered that extracellular vesicles released by liver cells in a mouse model of alcoholic steatohepatitis contain a miRNA signature detectable in the blood.READ MORE